[61A6-61A6];[61B2-61B2];
A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
61A6;61B2
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Viable in combination with Df(3L)BSC121.
Homozygotes show embryonic lethality, frequently arresting by stage 8.
Homozygous embryos show axon guidance defects characteristic of increased fasciculation in the ISNb pathway (73.9% of hemisegments), in the SNa pathway (69.0% of hemisegments) and in the central nervous system (58.9% of hemisegments).
Limits computationally determined from location of progenitor P insertion on genome sequence between P{PZ}trh10512 and P{EP}EP3104EP3104